Catalyst Wire Dossier Catalyst Wire Dossier

G/P

glecaprevir/pibrentasvir
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for G/P, covering 2020-02-05 to 2022-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P [Phase 3]

See pricing